- Home
- SHIP vs ACIU Comparison
SHIP vs ACIU Comparison
Compare SHIP & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- ACIU
- Stock Information
- Founded
- SHIP 2008
- ACIU 2003
- Country
- SHIP Greece
- ACIU Switzerland
- Employees
- SHIP N/A
- ACIU N/A
- Industry
- SHIP Marine Transportation
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- SHIP Consumer Discretionary
- ACIU Health Care
- Exchange
- SHIP Nasdaq
- ACIU Nasdaq
- Market Cap
- SHIP 183.3M
- ACIU 213.3M
- IPO Year
- SHIP 2007
- ACIU 2016
- Fundamental
- Price
- SHIP $8.22
- ACIU $3.53
- Analyst Decision
- SHIP Strong Buy
- ACIU Strong Buy
- Analyst Count
- SHIP 1
- ACIU 2
- Target Price
- SHIP $11.00
- ACIU $10.00
- AVG Volume (30 Days)
- SHIP 129.1K
- ACIU 262.9K
- Earning Date
- SHIP 11-04-2025
- ACIU 11-04-2025
- Dividend Yield
- SHIP 9.25%
- ACIU N/A
- EPS Growth
- SHIP N/A
- ACIU N/A
- EPS
- SHIP 0.73
- ACIU N/A
- Revenue
- SHIP $147,718,000.00
- ACIU $36,362,036.00
- Revenue This Year
- SHIP N/A
- ACIU N/A
- Revenue Next Year
- SHIP $14.29
- ACIU $1,022.98
- P/E Ratio
- SHIP $11.37
- ACIU N/A
- Revenue Growth
- SHIP 1.66
- ACIU 86.71
- 52 Week Low
- SHIP $4.78
- ACIU $1.43
- 52 Week High
- SHIP $11.99
- ACIU $3.99
- Technical
- Relative Strength Index (RSI)
- SHIP 46.76
- ACIU 68.67
- Support Level
- SHIP $8.18
- ACIU $2.70
- Resistance Level
- SHIP $8.62
- ACIU $3.99
- Average True Range (ATR)
- SHIP 0.27
- ACIU 0.29
- MACD
- SHIP -0.11
- ACIU 0.09
- Stochastic Oscillator
- SHIP 16.24
- ACIU 80.31
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Geniuship, Premiership, Squireship, And Friendship.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.